ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)

Volume 12, 10 Issues, 2015

Download PDF Flyer

Current Alzheimer Research

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 34th of 192 in Clinical Neurology
  • 69th of 252 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Prof. Debomoy K. Lahiri
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.889
5 - Year: 3.933

Upcoming Articles (E-Pub Abstracts ahead of Print)

Frontiers for the early diagnosis of AD by means of MRI brain imaging and Support Vector Machines

Christian Salvatore, Petronilla Battista and Isabella Castiglioni.

View Abstract

Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?

Ilaria Vanzuli, Andrea Rivera, José Julio Rodríguez Arellano and Arthur Butt.

View Abstract

Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease

Antonio Giuliano Zippo and Isabella Castiglioni.

View Abstract

A Statistical Projection of MRI Brain Images for the Detection of Alzheimer's Disease

F.J. Martinez-Murcia, J.M. Gorriz, J. Ramirez and A Ortiz.

View Abstract

Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD

Francesca Gallivanone, Pasquale Anthony Della Rosa and Isabella Castiglioni.

View Abstract

Combining feature extraction methods to assist the diagnosis of Alzheimer’s disease

F. Segovia, J. M. G'orriz, J. Ram'ırez, C. Phillips and for the Alzheimer's Disease Neuroimaging Initiative.

View Abstract

Diagnosis of Neurodegenerative Diseases: the Clinical Approach

Manuel Gómez-Río, Manuel Moreno Caballero, Juan Manuel Górriz Sáez and Adolfo Mínguez Castellanos.

View Abstract

Cortical and subcortical changes in Alzheimer’s disease: a longitudinal and quantitative MRI study

Li Su, Andrew M. Blamire, Rosie Watson, Jiabao He, Benjamin Aribisala and John T O’Brien.

View Abstract

Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.

Adolfo Toledano, María-Isabel Álvarez, Adolfo Toledano-Díaz, José-Joaquín Merino and José Julio Rodríguez.

View Abstract

Blood-based biomarkers of Alzheimer´s disease: diagnostic algorithms and new technologies

Pedro Carmona, Marina Molina and Adolfo Toledano.

View Abstract

Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease

Dmitry Lim, J.J Rodríguez-Arellano, Vladimir Parpura, Robert Zorec, Fares Zeidán-Chuliá, Armando A. Genazzani and Alexei Verkhratsky.

View Abstract

Dysfunction of glutamate receptors in microglia may cause neurodegeneration

Mami Noda.

View Abstract

Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in Alzheimer,s disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?

José Joaquín Merino, Vilma Muñetón-Gómez, María-Isabel Alvárez and Adolfo Toledano-Díaz.

View Abstract

Eigenanatomy on fractional anisotropy imaging provides white matter anatomical features discriminating between Alzheimer’s Disease and Late Onset Bipolar Disorder

Ariadna Besga-Basterra, Darya Chyzhyk, Itxaso González-Ortega, Alexandre Savio, Borja Ayerdi, Jon Echeveste, Manuel Graña and Ana González-Pinto.

View Abstract

Untangling Alzheimer’s disease clinicoanatomical heterogeneity through selective network vulnerability – an effort to understand a complex disease

David Bergeron, Reda Bensaïdane and Robert Laforce Jr.

View Abstract

Microglia in Alzheimer's disease: the good, the bad and the ugly

Dario Tejera and Michael T Heneka.

View Abstract

Lymphocytes in Alzheimer’s disease pathology: Altered signaling pathways

Noemí Esteras, Carolina Alquézar, Ana de la Encarnación and Ángeles Martín-Requero.

View Abstract

Metabolic Control of Glia-Mediated Neuroinflammation

Mithilesh Kumar Jha, Dong Ho Park, Hyun Kook, In-Kyu Lee and Kyoungho Suk.

View Abstract

Rhein-huprine derivatives reduce cognitive impairment, synaptic failure and amyloid pathology in AβPPswe/PS-1 mice of different ages

FG Serrano, C Tapia-Rojas, FJ Carvajal, P Cisternas, E Viayna, Sola Irene, D Muñoz-Torrero and NC Inestrosa.

View Abstract View on PubMed

Aging in Down syndrome and the Development of Alzheimer’s disease Neuropathology.

Elizabeth Head, Ira T. Lott, Donna M. Wilcock and Cynthia A Lemere.

View Abstract

Prevalence of cognitive impairment and dementia in Malays – Epidemiology of Dementia in Singapore Study

S Hilal, CS Tan, S Xin, SM Amin, TY Wong, C Chen, N Venketasubramanian and MK Ikram.

View Abstract View on PubMed

Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome

E Hamlett, HA Boger, A Ledreux, CM Kelley, EJ Mufson, MF Falangola, DN Guilfoyle, RA Nixon, D Patterson, N Duval and AE Granholm.

View Abstract View on PubMed

Clinical Assessment of Cognitive Decline in Adults with Down Syndrome

M Sabbagh and J Edgin.

View Abstract View on PubMed

The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s disease

MF Iulita and CA Claudio Cuello.

View Abstract View on PubMed

Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in Alzheimer’s disease

S Serini and G Calviello.

View Abstract View on PubMed

Nitric Oxide Homeostasis in Neurodegenerative Diseases

L Hannibal.

View Abstract View on PubMed

The role of brain cholesterol and its oxidized products in Alzheimer's disease

AM Giudetti, A Romano, AM Lavecchia and S Gaetani.

View Abstract View on PubMed

Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer’s Disease

L Frings, TS Spehl, M Hüll and PT Meyer.

View Abstract

The Role of α-Synuclein in Neurodegenerative Diseases: From Molecular Pathways in Disease to Therapeutic Approaches

Al- Mansoori KM, Hasan MY, Al- Hayani A and El- Agnaf OMA.

View Abstract

Bioavailability of 13-desmethyl spirolide C and improvement of Alzheimer disease markers in vivo observed by Proton magnetic resonance spectroscopy and immunoblotting analysis

E Alonso, P. Otero, C. Vale, A. Alfonso, A. Antelo, L. Giménez-Llort, L. Chabaud, C. Guillou and L M Botana.

View Abstract

Pro-inflammatory cytokines IL-1? and TNF-? are not associated with blood homocysteine concentration in Alzheimer's disease

L. Veryard, E. Jones, G. Weaving, E. Smith, L. Cheek, A. Wickramasinghe and N Tabet.

View Abstract

Natural Modulators of Amyloid-Beta Precursor Protein Processing

Zhang C and Tanzi RE.

View Abstract

Current advancements in Ab luminescent probes and inhibitors of Ab aggregation

C-H Leung, DS-H Chan, VP-Y Ma, K-H Leung and H-J Zhong.

View Abstract


Related Journals

Related eBooks

Webmaster Contact: Copyright © 2015 Bentham Science